Tables

TABLE 1 TOP ACQUISITIONS IN CARDIOVASCULAR INDUSTRY 10
TABLE 2 HEART FAILURE DRUGS MARKET REVENUE' BY PRODUCT TYPE' 2018-2025 ($MILLION) 30
TABLE 3 PROJECTIONS - CVD TOTAL COSTS THROUGH 2035 41
TABLE 4 PRESCRIPTIONS USED IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
IN UK 43
TABLE 5 NUMBER OF PEOPLE WITH THE FOUR HEART CONDITIONS IN BRAZIL' 2015 48
TABLE 6 NOVARTIS AG: OFFERINGS 52
TABLE 7 NOVARTIS AG: RECENT DEVELOPMENTS 53
TABLE 8 GLAXOSMITHKLINE PLC: OFFERINGS 59
TABLE 9 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 60
TABLE 10 BAYER AG: OFFERINGS 64
TABLE 11 BAYER AG: RECENT DEVELOPMENTS 64
TABLE 12 ASTRAZENECA PLC: OFFERINGS 69
TABLE 13 ASTRAZENECA PLC: RECENT DEVELOPMENTS 70
TABLE 14 PFIZER' INC.: OFFERINGS 75
TABLE 15 PFIZER' INC.: RECENT DEVELOPMENTS 76
TABLE 16 MERCK & CO: SNAPSHOT 81
TABLE 17 MERCK & CO: RECENT DEVELOPMENTS 81
TABLE 18 BOEHRINGER INGELHEIM GMBH: SNAPSHOT 82
TABLE 19 BOEHRINGER INGELHEIM GMBH: RECENT DEVELOPMENTS 82
TABLE 20 BRISTOL-MYERS SQUIBB: OVERVIEW 83
TABLE 21 BRISTOL-MYERS SQUIBB: RECENT DEVELOPMENTS 83
TABLE 22 MYLAN N.V.: OVERVIEW 84
TABLE 23 MYLAN N.V.: RECENT DEVELOPMENTS 85
TABLE 24 SANOFI: SNAPSHOT 85
TABLE 25 SANOFI: RECENT DEVELOPMENTS 86
TABLE 26 AMGEN INC.: OVERVIEW 86
TABLE 27 AMGEN INC.: RECENT DEVELOPMENTS 87

LIST OF FIGURE

Charts

CHART 1 GLOBAL CARDIOVASCULAR DISEASE MARKET 2017 ($BILLION) 9
CHART 2 RESEARCH METHODOLOGY OF GLOBAL HEART FAILURE DRUGS MARKET 12
CHART 3 HEART FAILURE DRUGS MARKET REVENUE' 2018-2025 ($MILLION) 15
CHART 4 HEART FAILURE DRUGS MARKET SEGMENTATION 19
CHART 5 PORTERS 5 FORCES ON HEART FAILURE DRUGS MARKET 19
CHART 7 MARKET DYNAMICS - DRIVERS' RESTRAINTS & OPPORTUNITIES 24
CHART 8 DRO - IMPACT ANALYSIS OF HEART FAILURE DRUGS MARKET 27
CHART 9 KEY STAKEHOLDERS OF HEART FAILURE DRUGS MARKET 27
CHART 10 HEART FAILURE DRUGS MARKET SEGMENT REVENUE BY TECHNOLOGY TYPE' 2018 VS 2025
($ MILLION) 29
CHART 11 BETA BLOCKERS MARKET REVENUE' BY TECHNOLOGY TYPE 2018-2025 ($MILLION) 30
CHART 12 ACE INHIBITOR EDITING MARKET REVENUE' BY TECHNOLOGY TYPE 2018-2025 ($MILLION) 32
CHART 13 ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) MARKET REVENUE' BY TECHNOLOGY TYPE 2018-2025
($MILLION) 33
CHART 14 DIURETIC HEART FAILURE DRUGS MARKET REVENUE' BY TECHNOLOGY TYPE 2018-2025 ($MILLION) 34
CHART 15 OTHER HEART FAILURE DRUGS MARKET REVENUE' BY TECHNOLOGY TYPE 2018-2025
($MILLION) 35
CHART 16 HEART FAILURE DRUGS MARKET BY REGIONAL SEGMENTATION' 2018 ($MILLION) 37
CHART 17 HEART FAILURE DRUGS MARKET BY REGIONAL SEGMENTATION' 2025 ($MILLION) 38
CHART 18 HEART FAILURE DRUGS MARKET REVENUE IN NORTH AMERICA' 2018-2025 ($MILLION) 40
CHART 19 HEART FAILURE DRUGS MARKET REVENUE IN EUROPE' 2018-2025 ($MILLION) 43
CHART 20 HEART FAILURE DRUGS MARKET REVENUE IN ASIA PACIFIC' 2018-2025 ($MILLION) 46
CHART 21 HEART FAILURE DRUGS REVENUE IN REST OF THE WORLD' 2018-2025 ($MILLION) 47
CHART 22 NOVARTIS AG: OVERVIEW SNAPSHOT 51
CHART 23 NOVARTIS AG: BUSINESS UNITS 54
CHART 24 NOVARTIS AG: GEOGRAPHICAL PRESENCE 55
CHART 25 NOVARTIS AG: SWOT ANALYSIS 56
CHART 26 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 58
CHART 27 GLAXOSMITHKLINE PLC: BUSINESS UNITS 60
CHART 28 GLAXOSMITHKLINE PLC: GEOGRAPHIC PRESENCE 61
CHART 29 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 62
CHART 30 BAYER AG: OVERVIEW SNAPSHOT 64
CHART 31 BAYER AG: BUSINESS UNITS 64
CHART 32 BAYER AG: GEOGRAPHICAL PRESENCE 65
CHART 33 BAYER AG: SWOT ANALYSIS 66
CHART 34 ASTRAZENECA PLC: OVERVIEW SNAPSHOT 68
CHART 35 ASTRAZENECA PLC: BUSINESS UNITS 71
CHART 36 ASTRAZENECA PLC: GEOGRAPHIC PRESENCE 72
CHART 37 ASTRAZENECA PLC: SWOT ANALYSIS 73
CHART 38 PFIZER' INC.: OVERVIEW SNAPSHOT 75
CHART 39 PFIZER' INC.: BUSINESS UNITS 77
CHART 40 PFIZER' INC.: GEOGRAPHIC PRESENCE 77
CHART 41 PFIZER' INC: SWOT ANALYSIS 78